Results 71 to 80 of about 74,576 (156)

Disseminated rhino-orbital-cerebral mucormycosis in Philadelphia chromosome-positive mixed phenotype acute leukemia: a case report and literature review. [PDF]

Front Med (Lausanne)
Zhou Y, He M, Zhang Q, Yao J, Wang Z, Chen B, Guo J, Gao F, Liu Z.   +8 more
europepmc   +1 more source

Poor prognostic implication of CDKN2 deletion in adult patients with Philadelphia chromosome-positive ALL. [PDF]

Blood Cancer J
Park SY, Kwag D, Jung J, Min GJ, Park SS, Park S, Lee SE, Cho BS, Eom KS, Kim YJ, Kim HJ, Min CK, Cho SG, Kim Y, Kim M, Lee S, Yoon JH.   +16 more
europepmc   +1 more source

[Philadelphia chromosome].

Postepy biochemii, 2003
Ireneusz, Majsterek, Janusz, Błasiak
openaire   +1 more source

P2RX1 promotes mitochondrial apoptosis via calcium/CaM KII-mediated suppression of PI3K/Akt signaling in Philadelphia chromosome-positive acute lymphoblastic leukemia. [PDF]

Front Pediatr
Li XB, Ren Q, Ye XM, Li JL, Feng LG.
europepmc   +1 more source

The combination of a tyrosine kinase inhibitor and blinatumomab in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or Philadelphia chromosome-like acute lymphoblastic leukemia. [PDF]

Cancer Med
Wu X, Lu S, Zhang X, Yang Z, Sun A, Wu D, Zhou H, Miao M.   +7 more
europepmc   +1 more source

Rapid development of Philadelphia chromosome-negative AML in a CML patient with sustained major molecular response to tyrosine kinase inhibitor therapy. [PDF]

Leuk Res Rep
Liu H, Sun Y, Li L, Zhang Y, Zhou Y, Zeng P, Yue L.   +6 more
europepmc   +1 more source

Impact of clinical response and treatment tolerability on HRQoL in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib. [PDF]

Ann Hematol
Ashaye A, Shi L, Aldoss I, Montesinos P, Vachhani P, Rocha V, Papayannidis C, Leonard JT, Baer MR, Ribera JM, Wu Y, Hennessy M, Vorog A, Guo S.   +13 more
europepmc   +1 more source

Efficacy and safety of the third-generation tyrosine kinase inhibitor Olverembatinib in relapsed and persistent minimal residual disease positive Philadelphia chromosome-positive acute lymphoblastic leukemia patients. [PDF]

Front Med (Lausanne)
Jiang X, Zhou M, Ma J, Ji Q, Li X, Ma S, Chen C.   +6 more
europepmc   +1 more source

Targeting senescent stemlike subpopulations in Philadelphia chromosome-like acute lymphoblastic leukemia.

Blood
Ding YY, Sussman JH, Madden K, Loftus JP, Chen RK, Falkenstein CD, Bárcenas López DA, Hottman DA, Mathier B, Yu W, Xu J, Chen C, Chen CH, He B, Bandyopadhyay S, Zhang Z, Lee D, Wang H, Peng J, Dang CV, Tan K, Tasian SK.   +21 more
europepmc   +1 more source

Differential expression and functional analysis of circular RNAs and m6A modifications in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. [PDF]

Sci Rep
Xie L, Xu Y, Fan C, Liao M, Zhou G, Fen C, Ma L, Wen FQ.   +7 more
europepmc   +1 more source